Hisaki Fujii

Hisaki Fujii is a seasoned medical professional with extensive experience in oncology and pediatrics. Currently serving as the Senior Medical Director at Astellas Pharma Inc., Hisaki Fujii leads global medical initiatives for KRAS programs. Prior roles include Medical Director at Amgen, overseeing early development in oncology, and Medical Advisor at Eli Lilly and Company, focusing on early phase oncology. Hisaki Fujii also has a substantial clinical background, including positions as Clinical Fellow at the Hospital for Sick Children and Assistant Professor at Yokohama City University in hematology and oncology. Hisaki's academic credentials are supported by a PhD in Pediatrics from Yokohama City University and a medical degree from Nihon University School of Medicine.